Hot Stocks: Brokerages view on Aurobindo Pharma, Apollo Hospitals, Suzlon & Titan Company

June 3, 2024

Top brokerage firms like Macquarie maintained an outperform rating on Aurobindo Pharma, raising the target price to Rs 1,385. Aurobindo Pharma signed a master service agreement with Merck Sharp & Dohme, leading to a biologics CMO contract with TheraNym.

More To Explore

Banks look to shift focus to MCLR-linked loans ahead of rate cuts to protect margins

Amid expectations of a softer rate cycle, several banks plan to raise the share of MCLR-linked loans to protect net interest margins from falling sharply

February 7, 2025

Aadhar Housing Finance Q3 profit rises 17% on steady biz growth

The lender’s total income stood 19% higher at ₹785 crore, against ₹659 crore. Its assets under management grew 21% year-on-year to ₹23,976 crore at the

February 7, 2025

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003